| Name | Title | Contact Details |
|---|
Amarex offers more than capable hands. We are a consultative group of clinical researchers, always ready to go out 'on the limb' and give our own recommendations for solving the challenges clients face over the course of a clinical development program or
At PanOptica, our aim is to develop new ocular therapies that help patients see their very best throughout their lives. Many patients with common eye diseases suffer debilitating vision loss, despite currently available treatments. At PanOptica, we understand the critical role vision plays in a patient`s quality of life. And we know the frustration eye care professionals face when they are unable to treat their patients successfully. Today, significant progress is being made in the field of ophthalmology, with small laboratories and large pharmaceutical companies alike exploring newer, more effective treatments for sight-threatening diseases. PanOptica seeks to license and develop these innovative therapeutics, which may include improvements to existing therapies or entirely new treatments for previously untreatable disorders. Our lead development compound, PAN-90806 , is a novel, small-molecule selective VEGF receptor antagonist that shows promise as a topical treatment for wet age-related macular degeneration and diabetic retinopathy.
Andwin Scientific specializes in product distribution both as a distributor to direct end using companies, and as a supplier/vendor to national and international supply houses. This effort is supported by offices in North Carolina and Illinois
Veterinary Care Group Animal Hospital in Astoria, Bayside, Forest Hills, Glen Oaks, Little Neck, Middle Village, Oyster Bay, Westbury, NY
Ice Biotech, Inc. is a Dundas, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.